This Analyst Thinks AMD Stock Could Soar Over 120%. Should Investors Buy This Beaten-Down AI Stock?
Advanced Micro Devices (NASDAQ: AMD) has been ahead of the curve in terms of the AI sell-off trend. The chip stock peaked in March 2024 and has trended lower ever since, and is now down by around 50% from its all-time high.
However, numerous Wall Street analysts have much higher price targets on AMD, suggesting that it could be a screaming buy here. Hans Mosesmann of Rosenblatt Securities has the highest price target on Wall Street for AMD stock at $225. With AMD shares hovering around $100, that indicates a potential 12-month upside of around 125%.
Any investor would be happy with that kind of return, but is it realistic to expect?
AMD has always produced great hardware, but it never seems to be the leader when it matters most. In the early 2000s, Intel was the top dog in the processor space, while AMD was only allowed to stick around because Intel didn't want to be broken up for being a monopoly. History has repeated itself in the AI chip race, where Nvidia is dominating the incredibly important data center market.
In Q4, AMD's data center division generated $3.9 billion in revenue, up 69% year over year. However, Nvidia continued to eat AMD's lunch. In its fiscal 2025 fourth quarter, which ended Jan. 26, its data center revenue grew by 93% to $35.6 billion. So, not only is AMD's data center division much smaller than Nvidia's, but it's also growing at a slower rate. That's not a winning combination, and is a big reason why AMD's stock has been such a poor performer recently.
The core of the investment thesis for AMD in early 2024 was that onlookers expected that it would start to gain some ground on Nvidia throughout the year as the largest AI chip buyers started to focus more on hardware geared toward inference rather than training. However, that trend didn't emerge, and Nvidia also didn't lose any ground on the inference front as it launched its new Blackwell architecture graphics processing units (GPUs).
Furthermore, AMD hasn't been doing great in its other markets. Its gaming revenue was down 59% year over year in Q4, while embedded process revenue decreased by 13%. Client revenue was a bright spot, up 58% year over year to $2.3 billion. However, the PC market isn't really growing in size, so that revenue stream will continue to be quite cyclical.
Still, despite AMD's somewhat disappointing Q4 results, its overall revenue grew by 24%, and profits rose by 42%. Most companies and their shareholders would be happy with those results, but because AMD hasn't been gaining ground on its key rival, the stock price has continued to sink.
This is where the new AMD investment thesis comes in, as it's starting to look like a value play.
AMD's stock isn't necessarily dirt cheap from a trailing earnings perspective. For a few recent quarters, the business wasn't optimized for earnings, so its trailing earnings multiple looks inflated. As a result, investors would be better served to use the forward price-to-earning (P/E) ratio to gauge the stock's valuation, as that metric is unaffected by the one-time events that skewed the trailing earnings metric.
At 21.5 times forward earnings, AMD trades at a slight premium to the S&P 500, which is currently valued at 20.5 times forward earnings. Given that AMD is expected to grow its revenue by 23.4% and 20.7% in 2025 and 2026, respectively, that slight premium seems like a reasonable price to pay.
Could AMD stock rise by 125% in the next year, as Hans Mosesmann projects? I doubt it. That would give AMD a ridiculously high multiple for a company that is not a best-in-class provider. However, I think market-beating returns are certainly attainable from today's price, and investors willing to hold onto the stock for three to five years will likely beat the market if they take positions in the stock now.
Before you buy stock in Advanced Micro Devices, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Advanced Micro Devices wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $720,291!*
Now, it's worth noting Stock Advisor's total average return is 838% — a market-crushing outperformance compared to 164% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of March 18, 2025
Keithen Drury has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, and Nvidia. The Motley Fool recommends the following options: short May 2025 $30 calls on Intel. The Motley Fool has a disclosure policy.
This Analyst Thinks AMD Stock Could Soar Over 120%. Should Investors Buy This Beaten-Down AI Stock? was originally published by The Motley Fool
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Analyst Forecasts For Verve Therapeutics, Inc. (NASDAQ:VERV) Are Surging Higher
Verve Therapeutics, Inc. (NASDAQ:VERV) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus statutory numbers for both revenue and earnings per share (EPS) increased, with their view clearly much more bullish on the company's business prospects. Investor sentiment seems to be improving too, with the share price up 6.4% to US$4.63 over the past 7 days. It will be interesting to see if this latest upgrade is enough to kickstart further buying interest in the stock. Our free stock report includes 3 warning signs investors should be aware of before investing in Verve Therapeutics. Read for free now. Following the upgrade, the consensus from ten analysts covering Verve Therapeutics is for revenues of US$39m in 2025, implying a concerning 34% decline in sales compared to the last 12 months. Losses are expected to increase substantially, hitting US$2.40 per share. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$24m and losses of US$2.67 per share in 2025. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven. Check out our latest analysis for Verve Therapeutics Despite these upgrades, the analysts have not made any major changes to their price target of US$24.33, implying that their latest estimates don't have a long term impact on what they think the stock is worth. One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. These estimates imply that sales are expected to slow, with a forecast annualised revenue decline of 42% by the end of 2025. This indicates a significant reduction from annual growth of 109% over the last three years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 17% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Verve Therapeutics is expected to lag the wider industry. The highlight for us was that the consensus reduced its estimated losses this year, perhaps suggesting Verve Therapeutics is moving incrementally towards profitability. Fortunately, they also upgraded their revenue estimates, and are forecasting revenues to grow slower than the wider market. The lack of change in the price target is puzzling, but with a serious upgrade to this year's earnings expectations, it might be time to take another look at Verve Therapeutics. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Verve Therapeutics analysts - going out to 2027, and you can see them free on our platform here. Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
an hour ago
- Yahoo
Is Intel Stock a Buy or Sell?
Intel is struggling in its core CPU markets, and its foundry effort has yet to pay off. However, a new CEO is refocusing and streamlining the company. Intel's manufacturing technology has advanced in the past few years, setting the stage for a successful turnaround. 10 stocks we like better than Intel › Semiconductor giant Intel (NASDAQ: INTC), once overwhelmingly dominant in its core central processing unit (CPU) markets, is scrambling to turn itself around. Market-share losses, missed opportunities in artificial intelligence (AI), and an expensive bet on becoming a foundry have all been weighing on the stock. While there are certainly legitimate reasons to sell, Intel stock still looks like a solid buy for long-term investors with plenty of patience. Intel fell into a common trap for companies that dominate their core markets -- complacency. Prior to AMD's renaissance, which began around 2017 with the first iteration of its Zen-based CPUs, Intel faced little competition from its rival. Back in 2017, Intel's desktop PC CPU market share was nearly 90%, and its server CPU market share topped 98%. The company appeared untouchable, and its in-house manufacturing gave it an important edge. Fast forward to today, and Intel's dominance has clearly deteriorated. While Intel remains the market-share leader, as of mid-2024, its share of the desktop CPU market had fallen below 80%, and its share of the server CPU market was around 75%. AMD now has great products available in both markets, putting pressure on Intel's core business. Intel's manufacturing technology fell woefully behind TSMC, which AMD uses to make its chips. Compounding Intel's problems are a weak PC market coming out of the pandemic-era boom and a hard shift in data center spending toward AI accelerators. Intel attempted to battle Nvidia in the AI accelerator market with its Gaudi chips, but the company fell well short of its own targets and has largely abandoned the effort. Intel's annual revenue has tumbled from more than $75 billion a few years ago to around $53 billion, and profits have vanished. Given these developments, it's all too easy to write off Intel's ongoing turnaround efforts. Despite plenty of problems and headwinds plaguing Intel, there's still a lot to like about its long-term prospects. Under new CEO Lip-Bu Tan, Intel is set to get serious about reining in its costs with a planned layoff over the summer. Bringing its cost structure down to reflect its current market position is critical to getting the company back on its feet. In the products business, Tan plans to eliminate layers of middle management and put the focus back on engineering. In the foundry business, Tan will emphasize listening to customers and adapting as needed to bring in enough external customers to make the company's massive manufacturing investments pay off. The Intel 18A manufacturing process, which is now complete and set for volume production later this year, has the potential to be a big winner for the company. The process delivers significant performance and efficiency gains over Intel's previous processes, and it's the first process available that includes backside power delivery. Intel now must scale up the process and achieve acceptable yields. Intel 18A will be used for the company's upcoming Panther Lake PC chips, which could give it a key advantage over AMD. It has won some external customers for Intel 18A, but not nearly enough. Panther Lake could act as a proof of concept for potential customers that are on the fence about committing to Intel for manufacturing. With a new focus on engineering, a plan for a streamlined organization capable of moving faster, and manufacturing technology that has advanced drastically over the past few years, Intel has all the pieces in place for a successful turnaround. Intel stock trades for around 0.9 times book value, meaning that the company is valued at less than its assets minus liabilities. While this valuation metric has limitations, Intel's is currently hovering around a multidecade low. Intel stock isn't for the impatient. The company must stabilize and then grow its CPU market share, cut costs and enact layoffs without killing morale or losing its best talent, and win multiple large external customers for its foundry. To make things more challenging, Intel faces a highly uncertain economic environment and U.S. trade policies that can change on a whim. Still, given Intel's deeply pessimistic valuation and a new CEO ready to make the painful but necessary changes to get the company back on track, Intel stock has the potential to deliver market-beating gains if the turnaround shows any meaningful signs of progress. Before you buy stock in Intel, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Intel wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Timothy Green has positions in Intel. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. Is Intel Stock a Buy or Sell? was originally published by The Motley Fool
Forbes
an hour ago
- Forbes
AppLovin Stock: Worth It At $365?
The AppLovin Corporation logo appears on a smartphone screen in this illustration photo in Reno, ... More United States, on December 20, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images) AppLovin (NASDAQ:APP), a firm that assists mobile app developers in publishing and promoting their applications, has excelled over the past year, though it has experienced some ups and downs in 2025. While the stock dropped nearly 57% from the peaks observed in early February 2025 following a report from a short-seller claiming AppLovin violated service terms and exaggerated the success of its e-commerce operations, these claims have yet to be substantiated, and the stock saw a strong recovery after reporting solid earnings in the first quarter. The stock is currently approximately 7% up year-to-date in 2025 and has increased nearly 4.5x over the previous year. Demand for Axon 2.0, AppLovin's exclusive machine learning algorithm for ad placement, has surged. The software effectively determines which ad to show, to which user, and at what time in order to optimize click-through rates or user engagement. While this resembles the strategies employed by Meta and Google, Axon is specifically designed for mobile app advertising. The company's advertising platform reported impressive revenue growth of 71% year-over-year in Q1 2025, achieving $1.16 billion. Overall financial results have also been strong, with revenue soaring nearly 40% year-over-year, and adjusted EBITDA experiencing an increase close to 83%. Although the bulk of the company's revenue still comes from advertisements for mobile gaming applications, it is concentrating on expanding its e-commerce sector. Nevertheless, it remains uncertain how effective this initiative will be, as AppLovin possesses an extensive dataset in gaming but may lack the comprehensive first-party e-commerce data that competitors like Meta and Alphabet have. That being said, despite its impressive growth and success, the AppLovin stock may be a challenging choice at its current price of approximately $360. We believe there is little reason for concern regarding APP stock, which makes it appealing, but it is also very responsive to negative events due to its elevated valuation. We reached this conclusion by comparing APP's current valuation with its operational performance over the past few years, as well as its current and historical financial positions. Our evaluation of AppLovin according to key metrics such as Growth, Profitability, Financial Stability, and Downturn Resilience indicates that the company possesses a very strong operational performance and financial standing, as elaborated below. Nonetheless, if you are looking for potential with lower volatility than individual stocks, the Trefis High Quality portfolio offers a viable alternative - having outperformed the S&P 500 and delivered returns greater than 91% since its founding. Separately, see – Should You Buy CRWV Stock After A Whopping 4x Rise? Based on the amount you pay per dollar of sales or profit, APP stock appears to be very expensive relative to the overall market. • AppLovin has a price-to-sales (P/S) ratio of 25.1 compared to a figure of 3.0 for the S&P 500 • Additionally, the company's price-to-free cash flow (P/FCF) ratio stands at 50.8 compared to 20.5 for the S&P 500 • Furthermore, it has a price-to-earnings (P/E) ratio of 67.1 compared to the benchmark's 26.4 AppLovin's Revenues have substantially increased over the last few years. • AppLovin has experienced an average revenue growth rate of 23.2% over the last 3 years (versus an increase of 5.5% for the S&P 500) • Its revenues have risen 41.6% from $3.6 billion to $5.1 billion in the past 12 months (compared to a rise of 5.5% for the S&P 500) • Moreover, its quarterly revenues increased by 40.3% to $1.5 billion in the most recent quarter from $1.1 billion a year prior (versus a 4.8% increase for the S&P 500) AppLovin's profit margins are significantly higher than most companies within the Trefis coverage universe. • AppLovin's Operating Income over the last four quarters was $2.4 billion, indicating a significantly high Operating Margin of 46.5% (compared to 13.2% for the S&P 500) • AppLovin's Operating Cash Flow (OCF) for this period was $2.5 billion, indicating a significantly high OCF Margin of 49.4% (versus 14.9% for the S&P 500) • For the last four-quarter span, AppLovin's Net Income was $1.9 billion - reflecting a significantly high Net Income Margin of 37.4% (compared to 11.6% for the S&P 500) AppLovin's balance sheet appears solid. • AppLovin reported a Debt figure of $3.7 billion at the end of the most recent quarter, while its market capitalization is $124 billion (as of 6/13/2025). This results in a very strong Debt-to-Equity Ratio of 2.9%(in contrast to 19.9% for the S&P 500). [Note: A low Debt-to-Equity Ratio is preferable] • Cash (including cash equivalents) constitutes $551 million of the $5.7 billion in Total Assets for AppLovin. This gives rise to a moderate Cash-to-Assets Ratio of 9.7% (in comparison to 13.8% for the S&P 500) APP stock has underperformed compared to the benchmark S&P 500 index during several recent downturns. While investors remain hopeful for a smooth economic adjustment in the U.S., the potential consequences of another recession could be severe. Our dashboard How Low Can Stocks Go During A Market Crash illustrates the performance of key stocks during and after the last six market crashes. • APP stock declined 91.9% from a high of $114.85 on 11 November 2021 to $9.30 on 27 December 2022, compared to a peak-to-trough drop of 25.4% for the S&P 500 • The stock completely rebounded to its pre-Crisis peak by 16 September 2024 • Since then, the stock has risen to a maximum of $510.13 on 17 February 2025 and currently trades at around $360 • APP stock dropped 36.7% from a high of $88.22 on 17 June 2021 to $55.88 on 16 August 2021, in comparison to a peak-to-trough decline of 33.9% for the S&P 500 • The stock completely recovered to its pre-Crisis high by 14 October 2021 In conclusion, AppLovin's performance across the parameters mentioned previously can be summarized as follows: • Growth: Extremely Strong • Profitability: Extremely Strong • Financial Stability: Very Strong • Downturn Resilience: Weak • Overall: Very Strong Therefore, despite its high valuation, the stock seems attractive yet volatile due to its poor downturn resilience. This leads us to affirm that APP is a challenging stock to purchase. Not satisfied with the volatility associated with APP stock? The Trefis High Quality (HQ) Portfolio, which consists of 30 stocks, has demonstrated a history of comfortably outperforming the S&P 500 over the past four years. Why is this the case? As a collective, HQ Portfolio stocks have provided superior returns with less risk compared to the benchmark index; offering a smoother experience, as shown in the HQ Portfolio performance metrics.
